Company intelligence / Profile preview

Liqvor

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Liqvor is Armenia’s leading pharmaceutical manufacturer with over 30 years of experience. The company produces more than 60 types of medicines including intravenous and intramuscular injectables as well as sterile ophthalmic preparations. It was the first in the Caucasus to receive EU GMP certification for sterile pharmaceuticals production. Its products are exported internationally, especially within the CIS region.

Therapeutic areas: OphthalmologyHematologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

2 assets

ZEToptic-N

1 more asset in the full pipeline.

Partnerships

European Bank for Reconstruction and Development (EBRD) shareholder since August 2015

Beyond the preview

Go deeper on Liqvor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liqvor.